A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma

Figure 2

Development of lncRNA signature for the prediction of survival in LSCC patients. (a and b) Distribution of lncRNA-based classifier risk score. (c) Time-independent ROC curves with AUC values to evaluate predictive efficacy of the lncRNA signature risk score. (d) The Kaplan-Meier estimates of the patients’ survival status and time using the optimal lncRNA signature risk score cutoff which divided patients into low-risk and high-risk groups.

(a)

(b)

(c)

(d)